Tempus AI Expands Strategic Partnership Amid Oncology Boom [Yahoo! Finance]
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
Illumina Announces Changes to Board of Directors [Yahoo! Finance]